Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/XILIO-THERAPEUTICS-INC-128506326/nieuws/Xilio-Therapeutics-Inc-Kondigt-het-begin-aan-van-de-dosering-van-patienten-in-Fase-1-2-klinische-37608406/?utm_source=whatsapp&utm_medium=social&utm_campaign=share